- Home
- MREO vs SWBI Comparison
MREO vs SWBI Comparison
Compare MREO & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- SWBI
- Stock Information
- Founded
- MREO 2015
- SWBI 1852
- Country
- MREO United Kingdom
- SWBI United States
- Employees
- MREO N/A
- SWBI N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- SWBI Ordnance And Accessories
- Sector
- MREO Health Care
- SWBI Industrials
- Exchange
- MREO Nasdaq
- SWBI Nasdaq
- Market Cap
- MREO 369.2M
- SWBI 397.3M
- IPO Year
- MREO N/A
- SWBI N/A
- Fundamental
- Price
- MREO $2.30
- SWBI $9.37
- Analyst Decision
- MREO Strong Buy
- SWBI Buy
- Analyst Count
- MREO 7
- SWBI 2
- Target Price
- MREO $7.71
- SWBI $12.75
- AVG Volume (30 Days)
- MREO 1.7M
- SWBI 502.0K
- Earning Date
- MREO 05-14-2025
- SWBI 03-06-2025
- Dividend Yield
- MREO N/A
- SWBI 5.67%
- EPS Growth
- MREO N/A
- SWBI 16.02
- EPS
- MREO N/A
- SWBI 0.66
- Revenue
- MREO N/A
- SWBI $493,046,000.00
- Revenue This Year
- MREO N/A
- SWBI N/A
- Revenue Next Year
- MREO $61.92
- SWBI $3.86
- P/E Ratio
- MREO N/A
- SWBI $14.18
- Revenue Growth
- MREO N/A
- SWBI N/A
- 52 Week Low
- MREO $1.58
- SWBI $8.38
- 52 Week High
- MREO $5.02
- SWBI $17.33
- Technical
- Relative Strength Index (RSI)
- MREO 52.99
- SWBI 49.37
- Support Level
- MREO $1.58
- SWBI $8.38
- Resistance Level
- MREO $2.37
- SWBI $9.46
- Average True Range (ATR)
- MREO 0.21
- SWBI 0.39
- MACD
- MREO 0.04
- SWBI 0.07
- Stochastic Oscillator
- MREO 91.19
- SWBI 87.61
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About SWBI Smith & Wesson Brands Inc.
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.